Glenn Schulman | Investor Relations |
Richard Glickman | Emeritus Chairman & Chief Executive Officer |
Peter Greenleaf | Chief Executive Officer |
Dennis Bourgeault | Chief Financial Officer |
Neil Solomons | Chief Medical Officer |
Joseph Schwartz | SVB Leerink |
Ed Arce | H.C. Wainwright |
Greetings, and welcome to the Aurinia Pharmaceuticals First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Dr.